Elekta showcases China’s growing role in radiotherapy at ninth CIIE
The ninth China International Import Expo (CIIE) in Shanghai brought together three important milestones for Elekta: progress in bringing adaptive radiotherapy into routine clinical practice, clinical experience from more than 15,000 patients treated with Elekta Unity in China, and the 1,000th linear accelerator delivered from the Beijing facility.
Shorter workflows for adaptive treatment
Adaptive radiotherapy works best when it is coordinated across the whole workflow, rather than at individual points of treatment. That is the idea behind the comprehensive multi-modality adaptive radiotherapy ecosystem introduced at this year’s CIIE, combining MR and CBCT image guidance with treatment planning, delivery and digital workflows.
Building clinical evidence
During the expo, the China MRgRT White Paper 2026 was released, bringing together findings from multicenter clinical research and real-world practice across the country, and summarizing the latest developments in MR-guided adaptive radiotherapy in China.
The figures show how established the approach has become. Since it was approved in China in 2020, the Elekta Unity MR-guided radiotherapy system has been adopted by 17 institutions in the country. It has been used to treat more than 15,000 patients across over 40 tumor types, and that work has contributed to more than 180 scientific publications.
"China plays a central role in Elekta's global strategy. We continue to deepen local manufacturing and innovation while working closely with leading clinical teams to benefit patients in China and around the world," said Marie Helene Lauro, Head of Commercial, Elekta
Local manufacturing
The 1,000th linear accelerator delivered during the expo marks almost 20 years of local production in Beijing. The Beijing manufacturing and R&D base was established in 2006, with local production expanding over the years to cover the full product portfolio in 2025. Today, the facility has the broadest product portfolio of Elekta’s manufacturing sites worldwide.
A wider perspective
Anming Gong, Head of Region China, said: “Nine years at the CIIE have witnessed Elekta's journey from introducing global innovation to deepening localization and sharing Chinese manufacturing capabilities with the world. We will continue to fulfill our long-term commitment of 'In China, for China and for the world.”
From AI-driven workflows to locally manufactured systems, the developments shown at CIIE are part of Elekta's wider work to make radiotherapy available to more patients, in China and around the world.
For further information, please contact:
Kathy Pajari, Head of Corporate Communications
Tel: +46 76 255 6056, e-mail: [email protected]
Time zone: CET (Central European Time)